1. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double blind study. Antimicrobial Agents and Chemotherapy. 1984;25:20-24.

2. Gwaltney JM Jr. Rhinovirus. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practices of Infectious Diseases. New York:John Wiley and Sons; 1979: 1124-1134.

3. Kelly RW, Abel MH. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biology of Reproduction. 1983;28:883-889.

4. Halcomb WW. Mesa, Arizona. Personal communication, 1992.

5. Giec L, Wnuk-Wojnar AM, Trusz-Gluza M, et al. Epide- miologic evaluation of the coronary risk in physical workers on nonferrous metalworks. Part II. Coronary heart disease. Przegl Lek. 1980;37: 507-510. (English translation available)

6. Chandra RK. Excessive intake of zinc impairs immune responses. Journal of the American Medical Association. 1984;252:1443-1446.

7. Korant BD, Kaurer JC, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature. 1974; 248:588-590.

8. Merluzzi VJ, Cipriano D, McNeil D, et al. Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro. Research Communications in Chemical Pathology and Pharmacology. 1989;66: 425-440.

9. Geist FC, Bateman, JA, Hayden FG. In vitro activity of zinc salts against human rhinoviruses. Antimicrobial Agents and Chemotherapy. 1987;31: 622-624.

10. Al-Nakib W, Higgins PG, Barrow I. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. Journal of Antimicrobial Chemotherapy. 1987;20: 893-901.

11. Tyrrell DAJ. MRC AIDS Directed Programme, Public Health Laboratory Service, Centre for Applied Microbiology and Research, Porton Down, Salisbury, SP4 0JG, England. Personal communication, 1993.

12. Smith DS, Helzner EC, Nuttall CE Jr, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrobial Agents and Chemotherapy. 1989;33:646-648.

13. Briggs, Finch P, Matulewicz MC, et al. Complexes of copper(II), calcium, and other metal ions with carbohydrates: Thin-layer ligand-exchange chromatography and determination of relative stabilities of complexes. Carbohydrate Research. 1981;97:181-188.

14. Bannan B. General Nutrition Products, Greenville, SC. Unpublished data, 1989.

15. Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate for common cold. Danish Medical Bulletin. 1990;37:279-281.

16. Stör KB. Ahlgens International, Hvidovre, Denmark. Personal communication, 1992.

17. Eby GA, Davis DR, Halcomb WW. Effect of zinc orotate lozenges with zinc gluconate nasal spray in common cold treatment - a double-blind study. Unpublished, 1984.

18. Harisch G and Kretschmer M. Some aspects of a non-linear effect of zinc ions on the histamine release from rat peritoneal mast cells. Research Communications in Chemical and Pathological Pharmacology. 1987;55:39-48.

19. Tucci ER, Ke CH, Li NC. Linear free energy relationships for proton dissociation and metal complexation of pyrimidine acids. Journal of Inorganic Nuclear Chemistry, 1967;29:1657.

20. Aoki FY. Distribution and removal of human serum albumin-technetium 99m instilled intranasally. British Journal of Clinical Pharmacology. 1976;3:869-878.

21. Castleman M. Cold Cures. New York:Fawcett Columbine;1987:ch 19.

22. McCutcheon ML, Anderson JL and Cotton GE. University of Minnesota at Duluth. Unpublished data, 1987.

23. Schennum B. Quantum Inc., Eugene, Oregon. Unpublished data, 1989.

24. Berthon G, Germonneau P. Histamine as a ligand in blood plasma. Part 6. Aspartate and glutamate as possible partner ligands for zinc and histamine to favor histamine catabolism. Agents and Actions. 982;12: 619-629.

25. Martin RB. pH as a variable in free zinc ion concentration from zinc-containing lozenges (letter). Antimicrobial Agents and Chemotherapy. 1988;32: 608-609.

26. Farr BM, Conner EM, Betts RF. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrobial Agents and Chemotherapy. 1987;31:1183-1187.

27. Korant BD. E. I. du Pont de Nemours Co., Wilmington, DE. Personal communication, 1992.

28. Hill I, Locust NJ; Eby GA, Austin TX. Unpublished data, 1989.

29. Berthon G, May PM, Williams DR. Computer simulation of metal-ion equilibria in biofluids. Part 2. Formation constants for zinc(II)-citrate- cysteinate binary and ternary complexes and improved models of low-molecular-weight zinc species in blood plasma. Journal Chemical Society, Dalton. 1978;1433-1438.

30. Martell AE, Smith RM. Critical Stability Constants. New York: Plenum Press; 1991:vols 1-6.

31. Sillùn LG, Martell AE. Stability Constants of Metal-Ion Complexes. Special Publication No. 17. London:Burlington House; 1964.

32. Furia TE. Sequestrants in food. In: Furia TE, ed. CRC Handbook of Food Additives. 2nd ed. West Palm Beach:CRC Press; 1972.

33. Adler S, Fraley DS. Acid-base regulation, cellular and whole body. In: Arieff AI, DeFronzo RA, eds. Fluid, Electrolyte, and Acid-Base Disorders. New York:Churchhill Livingstone. 1985;1:227.

34. Guyton AC. Regulation of acid-base balance. In: Textbook of Medical Physiology. New York:W. B. Saunders Co. 1986:439.

35. Nordenström BE. Biologically Closed Electric Circuits. Clinical, Experimental and Theoretical Evidence for an Additional Circulatory System. Stockholm:Nordic Medical Publications; 1983.

36. Farr BM, Gwaltney JM. Zinc gluconate for the common cold: An evaluation of placebo matching. Journal of Chronic Diseases. 1987;40: 875-879.

37. Douglas RM, Miles HB, Moore BW. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrobial Agents and Chemotherapy. 1987;31:1263- 1265.

38. Williams RJE. F. H. Faulding & Company, Adelaide, South Australia, Personal communication, 1987.

39. Mohrle R. Effervescent tablets. In: Lieberman HA, Lachman L, Schwartz JB. eds. Pharmaceutical Dosage Forms: Tablets. New York:Marcel Dekker, Inc.; 1989:1.

40. Hacht B, Berthon G. Metal ion-FTS nonapeptide interactions. A quantitative study of zinc(II)-non-apeptide complexes (thymulin) under physiological conditions and assessment of their biological significance. Inorganica Chimica Acta. 1987;136: 165-171.

41 Berthon G, Varsamidis A, Blaquiere C, et al. Histamine as a ligand in blood plasma. Part 7. Malate, malonate, maleate and tartrate as adjuvants of zinc to flavor histamine tissue diffusion through mixed-ligand coordination. In vitro tests on lymphocyte proliferation. Agents and Actions. 1987;22:231-247.

42. Godfrey JC, Conant Sloane B, Smith DS. Zinc Gluconate and the Common Cold. The Journal of International Medical Research. 1992;20:234.

43. Zarembo JE, Godfrey JC, Godfrey NJ. Zinc(II) in Saliva: Determination of concentrations produced by different formulations of zinc gluconate lozenges containing common excipients. Journal of Pharmaceutic Sciences. 1992; 81:128-130.

44. Alemdaroglu T, Berthon G. Trace metal requirements in total parenteral nutrition II. Potentiometric study of the metal-ion equilibria in the zinc-histidine, zinc-glycine, zinc-cysteine-histinidine, zinc-glycine- histidine and zinc-glycine-cysteine systems under physiological conditions. Journal of Electroanalytical Chemistry and Interfacial Electrochemistry. 1981;128:49-62.